Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Assets Average (2016 - 2025)

Aptevo Therapeutics (APVO) has disclosed Assets Average for 10 consecutive years, with $21.3 million as the latest value for Q3 2025.

  • Quarterly Assets Average rose 41.75% to $21.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $21.3 million through Sep 2025, up 41.75% year-over-year, with the annual reading at $20.2 million for FY2024, 31.54% down from the prior year.
  • Assets Average hit $21.3 million in Q3 2025 for Aptevo Therapeutics, up from $12.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $70.1 million in Q2 2021 to a low of $12.0 million in Q1 2025.
  • Historically, Assets Average has averaged $34.4 million across 5 years, with a median of $31.9 million in 2023.
  • Biggest five-year swings in Assets Average: surged 220.5% in 2021 and later crashed 49.05% in 2024.
  • Year by year, Assets Average stood at $60.3 million in 2021, then plummeted by 45.35% to $33.0 million in 2022, then fell by 21.15% to $26.0 million in 2023, then crashed by 40.86% to $15.4 million in 2024, then skyrocketed by 38.66% to $21.3 million in 2025.
  • Business Quant data shows Assets Average for APVO at $21.3 million in Q3 2025, $12.0 million in Q2 2025, and $12.0 million in Q1 2025.